. 2019 Feb 22;19:169. doi: 10.1186/s12885-019-5365-2

Table 2.

Clinical characteristics and presence of PI3KCA mutations

ID	Year Primary tumor		First hepatectomy				Second hepatectomy				Third hepatectomy			Survival since primary (months)
ID	Year Primary tumor	Margins	Interval (months)^a	Intra hepatic Location	xhep	Margins	Interval (months)^a	Intra hepatic Location	xhep	Margins	Interval (months)^a	Intra hepatic Location	xhep	Survival since primary (months)
1	1989	R0	45	BI	No	–	53	BI	No	–	21	UL	No	140
2	1998	R1	65	UR	Yes	R0	40	UR	No					142
3	2002	–	22	UR	No	R0	57	UR	No					95
4	1984	–	65		No	R0	46	BI	No					195
5	1988	R0	27	UL	No	R1	26	UL	No					127
6	1998	R0	49	UR	No	R0	38	BI	Yes					112
7	1992	R0	46	UR	Yes	R0	28	UL	No					108
8	2005	R1	34	UR	No	R0	34	UR	Yes					93
9	1988	R0	30	UR	No	R1	34	UL	No	R1	34	BI	Yes	205
10	1993	R0	56	UL	No	R1	113	UL	Yes					182
11	2000	R0	34	UL	No	R1	36	UL	No					107
12	1998	R0	27	BI	No	R0	49	UL	No					120
13	1999	–	17	BI	No	R0	29	BI	Yes					72
14	1986	R0	82	UL	No	R0	40	UL	No	R0	28	UR	Yes	244
15	1999	–	62		No	R0	92	UL	Yes					157
16	1997	R0	60	UR	No	R0	44	UR	No					145
17	1992	R0	42	BI	No	R0	8	UR	No					75
18	2003	R1	10	BI	No	R0	32	BI	Yes					63
19	1990	R0	36	BI	No	R0	32	UR	No	R0	15	UR	No	93

^aTo previous event, xhep extra hepatic metastases, BI Bilobular, UL Unilateral Left, UR Unilateral Right, PI3KCA mutated tumors